__The Edinburgh Cancer Information Programme
Lung cancer is the most common cause of cancer death in the UK. Our study aims to assess whether early prehabilitation is feasible in these patients. Many patients aren’t fit for anticancer treatment, due to a combination of burden of disease, patient fitness and comorbidities. These issues affect energy levels and performance status, which results […]
Innovative new medicines used in conjunction with neoadjuvant chemotherapy (NACT) may lead to a higher pathological complete response (pCR), and therefore a better chance of survival for patients diagnosed with eTNBC cancer. The Edinburgh Cancer Informatics, in partnership with DATA-CAN, ran a retrospective, longitudinal cohort study using routinely collected data to better describe differences in […]
Collaboration with the Edinburgh Cancer Informatics team enabled an investigation of the Real-World Impact of stereotactic ablative body radiotherapy (SABR) along with other conventional methods (conventional radiotherapy and surgery) on Stage I Non-Small-Cell Lung Cancer (NSCLC) patients in South-East Scotland. A total of 1143 patients discussed at MDM between January 2012 and December 2019 were selected for this study from the Edinburgh Cancer Centre Lung […]
Brain Tumour Pathway – a REDCap Project Critical to accelerating the discovery of new therapies for brain tumours and their translation into the clinic, is to investigate diagnosis, treatment and outcomes at a population level, mapping this to molecular interrogation of resected tumour tissue, and liquid biopsies from patients. In collaboration with researchers at […]
This Data Linkage study exploits historically strong maternity and cancer registration data in Scotland to produce more evidence to help women in their decision making on pregnancy after treatment for early breast cancer. The impact of childbirth on survival after breast cancer remains controversial. National cancer and birth data were used to analyse an unbiased […]
Disparities in breast cancer care quality have reduced Regional variation in chemotherapy treatment for breast cancer across Scotland has reduced significantly over the past 15 years, according to a new study: December 2021 The findings suggest that there is now limited inequalities in treatment across the majority of the country’s 14 health boards. Experts from […]
Edinburgh was one of eight cancer centres from accross the world that was able to contribute real world data to a pooled analysis that validated RCB as a strong predictor in all breast cancer subtypes.
Prospects for future research and a reflection on lessons learned: The Bowel Cancer Intelligence UK Hub are working with Public Health Scotland and the University of Edinburgh to make Health Data available and research ready for the colorectal cancer research community. This webinar summarises the project and future opportunities. This introduces the paper sumarising the […]
Public Health Scotland webinar, SCRIS: How data is helping support improved cancer care services in Scotland’, took place on the 18 January 2021 and featured presentations from speakers involved in the implementation, delivery and use of the SCRIS project. Full details on the PHS website. Watch the presentations again: Professor Aileen Keel CBE – SCRIS: […]
